Preparation and in vitro Synergistic Osteogenic-promoting Effect of Puerarin/Mesoporous Bioactive Glass Composites
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Mesoporous Materials and Catalysis · Microencapsulation and Drying Processes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (34)
Show source-provided references
1. WEI Y, PAN H, YANG J, et al . Aligned cryogel fibers incorporated 3D printed scaffold effectively facilitates bone regeneration by enhancing cell recruitment and function. Science Advances , 2024, 10(6): eadk6722.10.1126/sciadv.adk6722 ↗
2. YU C, CHEN J, WANG T, et al . GelMA hydrogels reinforced by PCL@GelMA nanofibers and bioactive glass induce bone regeneration in critical size cranial defects. Journal of Nanobiotechnology , 2024, 22(1): 696.10.1186/s12951-024-02980-w ↗
3. MOY P K, AGHALOO T. Risk factors in bone augmentation procedures. Periodontology 2000 , 2019, 81(1): 76.10.1111/prd.12285 ↗
4. LALZAWMLIANA V, ANAND A, ROY M, et al . Mesoporous bioactive glasses for bone healing and biomolecules delivery. Materials Science and Engineering: C , 2020, 106: 110180.10.1016/j.msec.2019.110180 ↗
5. VALLET-REGI M, SALINAS A J. Mesoporous bioactive glasses for regenerative medicine. Materials Today Bio , 2021, 11: 100121.10.1016/j.mtbio.2021.100121 ↗
6. SCHUMACHER M, HABIBOVIC P, VAN RIJT S. Mesoporous bioactive glass composition effects on degradation and bioactivity. Bioactive Materials , 2021, 6(7): 1921.10.1016/j.bioactmat.2020.12.007 ↗
7. CUI Y, HONG S, JIANG W, et al . Engineering mesoporous bioactive glasses for emerging stimuli-responsive drug delivery and theranostic applications. Bioactive Materials , 2024, 34: 436.10.1016/j.bioactmat.2024.01.001 ↗
8. ZHOU Y X, ZHANG H, PENG C. Puerarin: a review of pharmacological effects. Phytotherapy Research , 2014, 28(7): 961.10.1002/ptr.5083 ↗
9. ZENG X, FENG Q, ZHAO F, et al . Puerarin inhibits TRPM3/miR-204 to promote MC3T3-E1 cells proliferation, differentiation and mineralization. Phytotherapy Research , 2018, 32(6): 996.10.1002/ptr.6034 ↗
10. YANG X, YANG Y, ZHOU S, et al . Puerarin stimulates osteogenic differentiation and bone formation through the ERK1/2 and p38-MAPK signaling pathways. Current Molecular Medicine , 2018, 17(7): 488.10.2174/1566524018666171219101142 ↗
11. YANG Y, CHEN D, LI Y, et al . Effect of puerarin on osteogenic differentiation in vitro and on new bone formation in vivo . Drug Design, Development and Therapy , 2022, 16: 2885.10.2147/DDDT.S379794 ↗
12. KANG S, BENNETT C N, GERIN I, et al . Wnt signaling stimulates osteoblastogenesis of mesenchymal precursors by suppressing CCAAT/enhancer-binding protein alpha and peroxisome proliferator-activated receptor gamma. Journal of Biological Chemistry , 2007, 282(19): 14515.10.1074/jbc.M700030200 ↗
13. LI B, WANG Y, GONG S, et al . Puerarin improves OVX-induced osteoporosis by regulating phospholipid metabolism and biosynthesis of unsaturated fatty acids based on serum metabolomics. Phytomedicine , 2022, 102: 154198.10.1016/j.phymed.2022.154198 ↗
14. PANG Z, WEI Y, WANG N, et al . Gel formation of puerarin and mechanistic study during its cooling process. International Journal of Pharmaceutics , 2018, 548(1): 625.10.1016/j.ijpharm.2018.07.038 ↗
15. ZHANG L. Pharmacokinetics and drug delivery systems for puerarin, a bioactive flavone from traditional Chinese medicine. Drug Delivery , 2019, 26(1): 860.10.1080/10717544.2019.1660732 ↗
16. HU Q, LI Y, ZHAO N, et al . Facile synthesis of hollow mesoporous bioactive glass sub-micron spheres with a tunable cavity size. Materials Letters , 2014, 134: 130.10.1016/j.matlet.2014.07.041 ↗
17. YUN H S, KIM S H, LEE S, et al . Synthesis of high surface area mesoporous bioactive glass nanospheres. Materials Letters , 2010, 64(16): 1850.10.1016/j.matlet.2010.04.053 ↗
18. HENCH L L, WILSON J. Surface-active biomaterials. Science , 1984, 226(4675): 630.10.1126/science.6093253 ↗
19. YANG S Y, HU Y, ZHAO R, et al . Quercetin-loaded mesoporous nano-delivery system remodels osteoimmune microenvironment to regenerate alveolar bone in periodontitis via the miR-21a-5p/ PDCD4/NF-κB pathway. Journal of Nanobiotechnology , 2024, 22(1): 94.10.1186/s12951-024-02352-4 ↗
20. ZHENG K, BOCCACCINI A R. Sol-Gel processing of bioactive glass nanoparticles: a review. Advances in Colloid and Interface Science , 2017, 249: 363.10.1016/j.cis.2017.03.008 ↗
21. LIGA S, VODĂ R, LUPA L, et al . Synthesis of Ag 2 O/Ag nanoparticles using puerarin: characterization, cytotoxicity, in ovo safety profile, antioxidant, and antimicrobial potential against nosocomial pathogens. Journal of Functional Biomaterials , 2025, 16(7): 258.10.3390/jfb16070258 ↗
22. GARCÍA-PERDIGUERO J C, GÓMEZ-CEREZO N, GISBERT- GARZARÁN M, et al . Unraveling the role of calcium in the osteogenic behavior of mesoporous bioactive glass nanoparticles. Acta Biomaterialia , 2025, 198: 482.10.1016/j.actbio.2025.04.005 ↗
23. CHEN M, WANG Y, YUAN P, et al . Multifunctional bioactive glass nanoparticles: surface-interface decoration and biomedical applications. Regenerative Biomaterials , 2024, 11: rbae110.10.1093/rb/rbae110 ↗
24. WANG X, WANG G, ZHANG Y. Research on the biological activity and doxorubicin release behavior in vitro of mesoporous bioactive SiO 2 -CaO-P 2 O 5 glass nanospheres. Applied Surface Science , 2017, 419: 531.10.1016/j.apsusc.2017.05.078 ↗
25. ANAND A, DAS P, NANDI S K, et al . Development of antibiotic loaded mesoporous bioactive glass and its drug release kinetics. Ceramics International , 2020, 46(4): 5477.10.1016/j.ceramint.2019.10.264 ↗
26. SOUNDRAPANDIAN C, MAHATO A, KUNDU B, et al . Development and effect of different bioactive silicate glass scaffolds: in vitro evaluation for use as a bone drug delivery system. Journal of the Mechanical Behavior of Biomedical Materials , 2014, 40: 1.10.1016/j.jmbbm.2014.08.007 ↗
27. ZHU Y, KASKEL S. Comparison of the in vitro bioactivity and drug release property of mesoporous bioactive glasses (MBGs) and bioactive glasses (BGs) scaffolds. Microporous and Mesoporous Materials , 2009, 118(1): 176.10.1016/j.micromeso.2008.08.046 ↗
28. ZHAO L, YAN X, ZHOU X, et al . Mesoporous bioactive glasses for controlled drug release. Microporous and Mesoporous Materials , 2008, 109(1): 210.10.1016/j.micromeso.2007.04.041 ↗
29. ALMASRI D, DAHMAN Y. Impact of composition and surfactant-templating on mesoporous bioactive glasses structural evolution, bioactivity, and drug delivery property. Journal of Biomaterials Applications , 2025, 39(9): 1064.10.1177/08853282241312040 ↗
30. VIMALRAJ S. Alkaline phosphatase: structure, expression and its function in bone mineralization. Gene , 2020, 754: 144855.10.1016/j.gene.2020.144855 ↗
31. QUARLES L D, YOHAY D A, LEVER L W, et al . Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. Journal of Bone and Mineral Research , 1992, 7(6): 683.10.1002/jbmr.5650070613 ↗
32. BROWN E M, MACLEOD R J. Extracellular calcium sensing and extracellular calcium signaling. Physiological Reviews , 2001, 81(1): 239.10.1152/physrev.2001.81.1.239 ↗
33. LIU Y K, LU Q Z, PEI R, et al . The effect of extracellular calcium and inorganic phosphate on the growth and osteogenic differentiation of mesenchymal stem cells in vitro : implication for bone tissue engineering. Biomedical Materials , 2009, 4(2): 025004.10.1088/1748-6041/4/2/025004 ↗
34. DANOUX C B, BASSETT D C, OTHMAN Z, et al . Elucidating the individual effects of calcium and phosphate ions on hMSCs by using composite materials. Acta Biomaterialia , 2015, 17: 1.10.1016/j.actbio.2015.02.003 ↗